Abstract:This study depicted the metabolite and microbiota trajectories across aging. Long‐lived subjects from the familial longevity cohort harbored a distinguished microbiome signature. A candidate metabolite, pinane thromboxane A2 (PTA2), was consistently higher in the individuals of familial longevity and their descendants. Functional analysis showed PTA2 enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Our findings provide insights into the association between gut microbiome and longevity and may facilitate the development of strategies for healthy aging. Gut microbiota associated with longevity plays an important role in the adaptation to damaging stimuli accumulated during the aging process. The mechanism by which the longevity‐associated microbiota protects the senescent host remains unclear, while the metabolites of the gut bacteria are of particular interest. Here, an integrated analysis of untargeted metabolomics and 16S rRNA gene sequencing was used to characterize the metabolite and microbiota profiles of long‐lived individuals (aged ≥90 years) in comparison to old‐elderly (aged 75–89 years), young‐elderly (aged 60–74 years), and young to middle‐aged (aged ≤59 years) individuals. This novel study constructed both metabolite and microbiota trajectories across aging in populations from Jiaoling county (the seventh longevity town of the world) in China. We found that the long‐lived group exhibited remarkably differential metabolomic signatures, highlighting the existence of metabolic heterogeneity with aging. Importantly, we also discovered that long‐lived individuals from the familial longevity cohort harbored a microbiome distinguished from that of the general population. Specifically, we identified that the levels of a candidate metabolite, pinane thromboxane A2 (PTA2), which is positively associated with aging, were consistently higher in individuals with familial longevity and their younger descendants than in those of the general population. Furtherly, functional analysis revealed that PTA2 potentiated the efficiency of microglial phagocytosis of β‐amyloid 40 and enhanced an anti‐inflammatory phenotype, indicating a protective role of PTA2 toward host health. Collectively, our results improve the understanding of the role of the gut microbiome in longevity and may facilitate the development of strategies for healthy aging.

Comprehensive 16S rRNA sequencing based microbiomes and 1H NMR based metabolomics reveal the relationships of aging and constipation

Research Progress on the Correlation Between Chronic Constipation and the Gut Microbiota in the Elderly

Gut Microbiota Community And Its Assembly Associated With Age And Diet In Chinese Centenarians

Correlation Between Fecal Characteristics and Intestinal Microflora in the Elderly

Metapangenomics reveals an increased proportion of an Escherichia coli-dominated enterotype in older Chinese people

Study on Alterations of Physiological Functions in Aged Constipation Rats with Fluid-Deficiency Based on Metabonomic and Microbiology Analysis

Multi-omics insights implicate the remodeling of the intestinal structure and microbiome in aging

Comprehensive gut microbiota composition and microbial interactions among the three age groups

Gut Microbial Features and Circulating Metabolomic Signatures of Frailty in Older Adults

Gut Microbiota Composition Changes in Constipated Women of Reproductive Age

Gastrointestinal Characteristics of Constipation from the Perspectives of Microbiome and Metabolome

Diminished representation of vitamin-B12-producing bacteria in constipated elders with frailty

Age-related Compositional Changes and Correlations of Gut Microbiome, Serum Metabolome, and Immune Factor in Rats

Role of Microbiota-Gut-brain Axis in Natural Aging-Related Alterations in Behavior

Su2006 – Fusobacterium Nucleatum May Promote Glycolysis Via Modulating Lncrna in Colorectal Cancer Cells

Structural difference analysis of adult's intestinal flora basing on the 16S rDNA gene sequencing technology

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging

Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging

Does Microbiome Contribute to Longevity? Compositional and Functional Differences in Gut Microbiota in Chinese Long-Living (>90 Years) and Elderly (65-74 Years) Adults

Comprehensive microbiomes and fecal metabolomics combined with network pharmacology reveal the effects of Jichuanjian on aged functional constipation

IDDF2020-ABS-0141 the Gut Microbiome and Serum Metabolome Orchestrate Healthy Aging and Longevity with Novel Implications for Renal Function